<DOC>
	<DOC>NCT01625871</DOC>
	<brief_summary>The cure rate of artemether/lumefantrine in the treatment of vivax malaria.</brief_summary>
	<brief_title>Artemether/Lumefantrine and Vivax Malaria</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Malaria, Vivax</mesh_term>
	<mesh_term>Lumefantrine</mesh_term>
	<mesh_term>Artemether</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Artemether-lumefantrine combination</mesh_term>
	<criteria>Patients with vivax malaria severe malaria pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>malaria</keyword>
	<keyword>vivax</keyword>
	<keyword>artemether/lumefantrine</keyword>
	<keyword>Sudan</keyword>
</DOC>